[ Price : $8.95]
Paradigm Therapeutics plans an NDA submission in the second half of this year for Zorblisa (SD-101), as a topical whole-body treat...[ Price : $8.95]
FDA approves a Teal Health PMA for the Teal Wand, the first at-home vaginal sample, self-collection device for cervical cancer scr...[ Price : $8.95]
FDA again misses a user fee review action decision in the wake of mass staff cuts, the third miss in a month this time it's a GSK...[ Price : $8.95]
Speakers at the DTC National conference suggest a ban on drug DTC ads is not very likely.[ Price : $8.95]
Former FDA commissioners Scott Gottlieb and Mark McClellan voice concerns about an HHS proposed reorganization of FDA that would c...[ Price : $8.95]
The FDA Office of Inspections and Investigations ombudsman program calls for establishing a dedicated Web page as a stakeholder ed...[ Price : $8.95]
FDA approves an Orchestra BioMed IDE to begin a pivotal clinical trial evaluating its next generation Virtue Sirolimus-AngioInfusi...[ Price : $8.95]
FDA grants Italfarmaco a fast track designation to givinostat for treating patients with polycythemia vera, a rare hematologic can...